Severe parkinsonism due to metoclopramide: The importance of early recognition;Ernstig parkinsonisme door metoclopramide Het belang van tijdige herkenning

Nederlands Tijdschrift voor Geneeskunde

Volumn 157, Issue 33, 2013, Pages

  De Ronde, Maurice W J ^a   Kingma, Hylke Jan ^a   Munts, Alexander G ^a  

^a Stichting Apotheek der Haarlemse Ziekenhuizen   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

METOCLOPRAMIDE; ANTIEMETIC AGENT;

AGED; ARTICLE; BALANCE IMPAIRMENT; BRADYKINESIA; CASE REPORT; DISEASE SEVERITY; DRUG WITHDRAWAL; FATALITY; FEMALE; HUMAN; PARKINSONISM; PNEUMONIA; POSTURAL INSTABILITY; RIGIDITY; TREMOR; CHEMICALLY INDUCED DISORDER; PARKINSON DISEASE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIEMETICS; FEMALE; HUMANS; METOCLOPRAMIDE; PARKINSON DISEASE, SECONDARY;

EID: 84885144870     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Esper CD, Factor SA. Failure of recognition of drug-induced parkinsonism in the elderly. Mov Disord. 2008;23:401-4.
2. Ganzini L, Casey DE, Hoffman WF, McCall AL. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders. Arch Intern Med. 1993;153:1469-75.
3. Bloem BR, van Laar T, Keus SH, et al. Multidisciplinaire richtlijn 'Ziekte van Parkinson'. Alphen aan den Rijn: Van Zuiden Communications; 2010.
4. Sharkey KA, Wallace JL. Treatment of disorders of bowel motility and water flux; anti-emetics; agents used in biliary and pancreatic disease. In: Brunton LL, Chabner BA, Knollmann BC, redacteuren. Goodman & Gilman's the pharmacological basis of therapeutics. 12e dr. Hfdst 46. New York: McGraw-Hill; 2011. p. 1323-50.
5. Van Harten PN. Acute dystonie. Ned Tijdschr Geneeskd. 1997;141:1471-4.
6. Pasricha PJ, Pehlivanov N, Sugumar A, Jankovic J. Drug insight: from disturbed motility to disordered movement - a review of the clinical benefits and medicolegal risks of metoclopramide. Nat Clin Pract Gastroenterol Hepatol. 2006;3:138-48.
7. Miller LG, Jankovic J. Metoclopramide-induced movement disorders. Clinical findings with a review of the literature. Arch Intern Med. 1989;149:2486-92.
8. Silva CC, Saconato H, Atallah AN. Metoclopramide for migration of naso-enteral tube. Cochrane Database Syst Rev. 2002;(4):CD003353.
9. Fedorowicz Z, Jagannath VA, Carter B. Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents. Cochrane Database Syst Rev. 2011;(9):CD005506.
10. Richtlijn 'Overdracht van medicatiegegevens in de keten; 2008.